Aparna Biosciences Corp. has been awarded the following grants providing funding of greater than $1,800,000
National Institutes of Health Small Business Innovation Research (SBIR) grants for development of:
- “In vivo RNAi nanoparticle cancer gene function reagent”
- “Hybrid synthetic targeted lenti-VLP nanoparticle for gene delivery”
- “Dual antigen nanoparticle vaccine system for bacillus infectious disease”
State of Maryland:
- MIPS Phase I, and Phase II grants to Dr. A . James Mixson, Univ MD Baltimore for “Therapy of Candida with HK-fluconazole conjugates”
- TEDCO MTTF Award for “Branched HK Polyamide (BHKP) Anti-fungal Therapeutic Development”
- Maryland 2009 Nanobiotechnology Research and Industry Grant for ”Targeted Anti-angiogenic siRNA nanoparticle to Treat Lung Cancer”
Montgomery County (Maryland):
- Technology Growth Program grant to support product development and marketing